Drug Therapy for Weight Loss: Effects on Lactation and Breastfeeding
Patients should monitor for: Unexpected blood glucose elevations without clear cause (dietary changes, illness, new medications) Recurrence of diabetes symptoms such as increased thirst, urination, or fatigue Persistent high blood glucose readings (300 mg/dL) or symptoms of diabetic ketoacidosis (nausea, vomiting, abdominal pain, fruity breath) Severe abdominal pain (possible pancreatitis) These clinical changes have multiple potential causes beyond medication potency loss
under the brand name Wegovy, for the treatment of adults with a body mass index (BMI) of 30 (obesity) or greater or BMI of 27 (overweight) or greater with at least one weight-related comorbid condition
Sergey Terushkin, MD, FACS As a bariatric surgeon and weight-loss specialist, Ive watched the evolution of obesity treatment for over a decade
Inflammation plays a crucial role in the pathogenesis of atherosclerosis 23,24 , and the observed reduction in CRP levels indicates that GLP-1RAs may reduce systemic inflammation, thereby stabilizing atherosclerotic plaques and reducing the risk of plaque rupture